Walleye Capital
OLMA icon

Walleye Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Walleye Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,247
Closed -$317K – 5061
2026
Q1 		$317K Buy
+21,247
New +$473K ﹤0.01% 3025
2025
Q2 		– Sell
-87,705
Closed -$330K – 4895
2025
Q1 		$330K Buy
87,705
+20,698
+31% +$104K ﹤0.01% 2883
2024
Q4 		$391K Buy
+67,007
New +$669K ﹤0.01% 3198
2024
Q2 		– Sell
-11,966
Closed -$135K – 5879
2024
Q1 		$135K Sell
11,966
-178
-1% -$2.3K ﹤0.01% 4211
2023
Q4 		$170K Sell
12,144
-144,885
-92% -$1.95M ﹤0.01% 3769
2023
Q3 		$1.94M Buy
+157,029
New +$1.6M 0.01% 1763
2023
Q2 		– Sell
-182,337
Closed -$633K – 4728
2023
Q1 		$633K Buy
182,337
+151,036
+483% +$616K 0.01% 1511
2022
Q4 		$76.7K Buy
+31,301
New +$91.3K ﹤0.01% 2432
2022
Q2 		– Sell
-71,414
Closed -$304K – 2623
2022
Q1 		$304K Sell
71,414
-119,109
-63% -$656K 0.01% 1305
2021
Q4 		$1.78M Buy
+190,523
New +$3.95M 0.06% 359

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Walleye Capital's OLMA Position: Q2 2026 in Review

Walleye Capital sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 21,247 shares — an estimated $317K sold.

Walleye Capital first reported a position in OLMA in Q4 2021 and held it in 10 quarters. The position peaked at $1.94M in Q3 2023. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Walleye Capital reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 21,247 Olema Pharmaceuticals shares in Q2 2026, an estimated $317K.
  • Walleye Capital first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 10 quarters.
  • Walleye Capital's Olema Pharmaceuticals position peaked at $1.94M in Q3 2023.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.